AtaiBeckley Inc.
ATAIDelisted Sep 11, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002081043
AtaiBeckley Inc. was delisted on Sep 11, 2026; its insiders filed their last Form 4 on Sep 11, 2026; 243 institutions reported holding it in 13F filings for Q2 2026, worth $710.6M in total; no superinvestor held it.
Key figures
- Market cap
- –
- Not available
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 243
- Q2 2026, +62 vs. previous quarter
- 13F value
- $710.6M
- Reported value at the end of Q2 2026
- Superinvestors holding
- 0
- At the end of Q2 2026
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $4.09M
- +1,227.6% year over year
- Net income, FY2025
- -$660.0M
- No comparable prior period
- Free cash flow, FY2025
- -$103.6M
- No comparable prior period
- Revenue, Q2 FY2026
- $1.70M
- +137.0% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2025: $660.0M (16142.0% of revenue).
Short interest
See short dataFrom FINRA, settlement date Aug 31, 2026.
- Short interest
- 19.2M
- Shares sold short
- Change
- +2.35M
- +13.9% vs. previous
- Days to cover
- 2.77
- At average daily volume
Superinvestors holding ATAI, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding ATAI at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by AtaiBeckley Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 9, 2026 (view filing)5:30 PM ET | Jul 7 | 2 days | Hershberg RobertDirector | SSale | −100.0K | $4.96 | −$496.0K | −50.0%100.0K after | 10b5-1 |
| Jun 29, 2026 (view filing) | Jun 25 | 4 days | Craig Kevin JamesChief Medical Officer | SSale | −42.6K | $4.51 | −$192.0K | −83.5%8.44K after | 10b5-1 |
| Jun 29, 2026 (view filing) | Jun 26 | 3 days | Kochendoerfer GerdChief Operating Officer | SSale | −50.0K | $5.00 | −$250.0K | −100.0%0 after | 10b5-1 |
| Apr 22, 2026 (view filing) | Apr 20 | 2 days | Craig Kevin JamesChief Medical Officer | SSale | −42.6K | $5.00 | −$212.9K | −83.5%8.44K after | 10b5-1 |
| Mar 24, 2026 (view filing) | Mar 20 | 4 days | Craig Kevin JamesChief Medical Officer | SSale | −100.0K | $3.55 | −$355.0K | −92.2%8.44K after | 10b5-1 |
| Jan 6, 2026 (view filing) | Jan 2 | 4 days | Feilding-Mellen CosmoDirector | SSale | −39.6K | $3.90 | −$154.4K | −0.5%7.66M after | |
| Aug 18, 2025 (view filing)6:00 PM ET | Aug 14 | 4 days | Angermayer Christian and 1 otherDirector, 10% Owner | PPurchase | +8.68M | $2.19 | +$19.0M | +20.5%51.0M after | |
| Mar 24, 2025 (view filing)5:00 PM ET | Mar 24 | Same day | Angermayer Christian and 1 otherDirector, 10% Owner | PPurchase | +1.80M | $1.40 | +$2.52M | +4.4%42.4M after | |
| Mar 24, 2025 (view filing) | Mar 21 | 3 days | Kirpekar SahilChief Business Officer | SSale | −48.6K | $1.35 | −$65.6K | −29.6%115.6K after | |
| Mar 24, 2025 (view filing) | Mar 21 | 3 days | Craig Kevin JamesChief Medical Officer | SSale | −11.6K | $1.35 | −$15.6K | −57.8%8.44K after |
Top 10 13F holders, Q2 2026
See all 243 holdersThe largest institutional positions in AtaiBeckley Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 25,574,573 | $134.8M | 0.00% | +18,739,273+274.2% | Added |
| Deep Track Capital, LP | 14,417,442 | $76.0M | 1.12% | +2,417,442+20.1% | Added |
| Vanguard Capital Management LLC | 11,747,249 | $61.9M | 0.00% | −14,149−0.1% | Reduced |
| State Street Corp | 8,287,054 | $43.7M | 0.00% | +7,142,699+624.2% | Added |
| Geode Capital Management, LLC | 6,933,309 | $36.5M | 0.00% | +4,423,335+176.2% | Added |
| Adage Capital Partners GP, L.L.C. | 5,642,758 | $29.7M | 0.04% | 00.0% | Unchanged |
| UBS Group AG | 4,424,701 | $23.3M | 0.00% | −3,002,166−40.4% | Reduced |
| Vanguard Portfolio Management LLC | 4,106,450 | $21.6M | 0.00% | +4,106,450 | New |
| Morgan Stanley | 3,843,253 | $20.3M | 0.00% | −9,519−0.2% | Reduced |
| Candriam Luxembourg S.C.A. | 3,039,399 | $16.0M | 0.07% | −46,980−1.5% | Reduced |
Holders of 5% or more of ATAI
See all 2 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of AtaiBeckley Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Apeiron Investment Group Ltd. | 13D/A | 24.00%56.6M shares | −0.30 ppfrom 24.30% | Feb 10, 20227 filings | Oct 20, 2025 | SEC |
| BlackRock, Inc. | 13G | 6.80%25.0M shares | New | Jul 27, 20261 filing | Jul 27, 2026 | SEC |